Biotech · Private company
SFJ Pharmaceuticals, Inc.
Track this companyFree. Adds SFJ Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials60 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- Bentracimab (PB2452) InfusionPhase 3 · HemorrhageClinicalTrials.gov · fetched Nov 12, 2026
- Aspirin (ASA) Oral Tablet - Pre-TreatmentPhase 2 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Bentracimab (PB2452) InfusionPhase 2 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- PB2452 InfusionPhase 2 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Ticagrelor Oral Tablet - Pre-TreatmentPhase 2 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Ticagrelor Oral Tablet - Pre-Treatment and Post-TreatmentPhase 2 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- BEMPEG With Pembrolizumab vs Pembrolizumab Alone in Patients With Metastatic or Recurrent HNSCC (PROPEL-36)PHASE2_PHASE3 · TERMINATED · started Mar 9, 2022ClinicalTrials.gov NCT04969861 · fetched Nov 12, 2026
- Bentracimab in Ticagrelor-treated Patients With Uncontrolled Bleeding or Requiring Urgent Surgery or Invasive ProcedurePHASE3 · COMPLETED · started Jul 15, 2020ClinicalTrials.gov NCT04286438 · fetched Nov 12, 2026
- Phase 2B Study to Evaluate the Efficacy of Bentracimab (PB2452) in Reversal of Ticagrelor in Subjects Aged 50-80 Years OldPHASE2 · COMPLETED · started Sep 24, 2019ClinicalTrials.gov NCT04122170 · fetched Nov 12, 2026
- Study to Evaluate the Safety, Tolerability, PK and PD of PB2452 in Healthy Younger, Older and Elderly SubjectsPHASE2 · COMPLETED · started Apr 16, 2019ClinicalTrials.gov NCT03928353 · fetched Nov 12, 2026
- Study to Evaluate the Safety, Tolerability, PK, and PD of PB2452 in Healthy VolunteersPHASE1 · COMPLETED · started Apr 3, 2018ClinicalTrials.gov NCT03492385 · fetched Nov 12, 2026
- Adjuvant Axitinib Therapy of Renal Cell Cancer in High Risk PatientsPHASE3 · TERMINATED · started Apr 1, 2012ClinicalTrials.gov NCT01599754 · fetched Nov 12, 2026